Dabur India Q1 result
Published On: Thursday, August 4, 2022 | By: Team KnowMyStock
India's leading Science-based Ayurveda major Dabur India Ltd today reported an 8.1% growth in Consolidated Revenue for the First Quarter of 2022-23 with an underlying Volume growth of 5% in the India FMCG business. Consolidated profit after tax (PAT) for the quarter ended June 2022 (Q1FY23) was at Rs 441 crore as compared to the year-ago period. The PAT has improved marginally by 0.6 percent from Rs 438 crore last year. On a sequential basis, it surged 50 percent from Rs 294 crore PAT recorded during the previous quarter. Dabur reported a Consolidated Revenue of Rs 2,822 Crore in the first quarter of the 2022-23 financial year, up from Rs 2,612 Crore in the same quarter a year ago. Consolidated Revenue for the quarter reported a 2-year CAGR of 19.4%. Growth in revenue was aided by modest volume growth across the healthcare (herbal) business as demand for its power brands is seen normalizing.
"Our brands continued to grow significantly ahead of the market, gaining market shares across all key categories. Despite the macro-economic headwinds, we remained focused on rolling our consumer-centric innovation that expanded our total addressable market, and report strong, sustainable, profitable growth. The demand environment remained stressed in view of the heavy inflation, which saw consumers switch to more affordable smaller packs of branded consumer goods. Both rural and urban demand growth have been at par for Dabur. Rural demand for Dabur was driven by the ahead-of-the-curve investments in expanding our rural footprint to over 91,500 villages in Q1, up from 89,800 villages in March 2022. Urban growth, on the other hand, was driven by new-age channels like Modern Trade, which grew by 42% during the quarter," Dabur India Ltd Chief Executive Officer Mr. Mohit Malhotra said.
We are on Telegram!
JOIN our telegram channel to receive updates on Financial News and Stock and FNO Tips.
Click Here!
Follow Us On:
